SCHEMBL21818747

SCHEMBL21818747

O=C(O)c1cc(Br)c2nccnc2c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TTR P02766 1/20 0.48
TPMT P51580 3/20 0.39
NPC1 O15118 3/20 0.38
RAB9A P51151 3/20 0.38
KDM4E B2RXH2 5/20 0.37
ALOX15 P16050 1/20 0.36
TSHR P16473 1/20 0.36
HIF1A Q16665 1/20 0.36
ALDH1A1 P00352 4/20 0.36
MAPT P10636 3/20 0.36
KDM6B O15054 1/20 0.36
TET3 O43151 1/20 0.36
KDM4A O75164 1/20 0.36
BBOX1 O75936 1/20 0.36
KDM5A P29375 1/20 0.36
KDM5C P41229 1/20 0.36
ASPH Q12797 1/20 0.36
KDM4D Q6B0I6 1/20 0.36
TET2 Q6N021 1/20 0.36
ALKBH5 Q6P6C2 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27402556 0.84 HTT (0.40) NPC1RAB9AKDM4ETSHRALDH1A1
SCHEMBL27402555 0.80 ALOX15 (0.44) NPC1RAB9AKDM4EALOX15TSHR
SCHEMBL19893490 0.78 TPMT (0.42) TTRTPMTNPC1RAB9AKDM4E
SCHEMBL19893538 0.78 TTR (0.48) TTRTPMTNPC1RAB9AKDM4E
SCHEMBL4204593 0.74 KDM4E (0.48) TTRKDM4EALDH1A1TDP1L3MBTL1
SCHEMBL19893002 0.74 CA12 (0.53) TTRTPMTRAB9ATSHRKDM4C
SCHEMBL24373627 0.72 ESR2 (0.39) KDM4EALDH1A1SMN1; SMN2TDP1MEN1
SCHEMBL3519604 0.71 KDM4E (0.45) TTRKDM4EALDH1A1EGLN3SMN1; SMN2
SCHEMBL17875688 0.71 NQO2 (0.45) KDM4EALOX15TSHRALDH1A1MAPT
SCHEMBL18228295 0.70 AKR1C3 (0.44) RAB9AKDM4EALDH1A1KDM6BTET3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12577243-B2 Monoacylglycerol lipase modulators JANSSEN PHARMACEUTICA NV (BE) 2026-03-17 US disclosed
EP-3856178-B1 MONOACYLGLYCEROL LIPASE MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2026-03-11 EP disclosed
CN-113164459-B Monoacylglycerol lipase modulators 詹森药业有限公司 2024-09-03 CN disclosed
US-11820766-B2 Monoacylglycerol lipase modulators JANSSEN PHARMACEUTICA NV (BE) 2023-11-21 US disclosed
US-20230145249-A1 Monoacylglycerol Lipase Modulators JANSSEN PHARMACEUTICA NV (BE) 2023-05-11 US disclosed
US-20220332713-A1 Monoacylglycerol Lipase Modulators JANSSEN PHARMACEUTICA NV (BE) 2022-10-20 US disclosed
CN-113164459-A Monoacylglycerol lipase modulators 詹森药业有限公司 2021-07-23 CN disclosed
US-20200102303-A1 Monoacylglycerol Lipase Modulators JANSSEN PHARMACEUTICA NV (BE) 2020-04-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220332713-A1 Monoacylglycerol Lipase Modulators MGLL, LPL, PNLIP TTR 3606/4885TPMT 4042/4885NPC1 868/4885
US-12577243-B2 Monoacylglycerol lipase modulators MGLL, LPL, FAAH TTR 3228/4885TPMT 2435/4885NPC1 212/4885
US-20200102303-A1 Monoacylglycerol Lipase Modulators MGLL, LPL, PNLIP TTR 3606/4885TPMT 4042/4885NPC1 868/4885
US-20230145249-A1 Monoacylglycerol Lipase Modulators MGLL, LPL, PNLIP TTR 3606/4885TPMT 4042/4885NPC1 868/4885
US-11820766-B2 Monoacylglycerol lipase modulators MGLL, LPL, PNLIP TTR 3606/4885TPMT 4042/4885NPC1 868/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.